COMMON STOCK PURCHASE WARRANT HEAT BIOLOGICS, INC.Common Stock Purchase Warrant • May 2nd, 2018 • Heat Biologics, Inc. • Pharmaceutical preparations • New York
THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, CEDE & CO or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York time) on _____________ (the "Termination Date") but not thereafter, to subscribe for and purchase from Heat Biologics, Inc., a Delaware corporation (the "Company"), up to ______ shares of common stock, par value $0.0002 per share (the "Common Stock") (as subject to adjustment hereunder, the "Warrant Shares"). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee (“DTC”) shall initially be the sole registered holder o
Heat Biologics, Inc. and Continental Stock Transfer & Trust Company, as Warrant Agent Warrant Agency Agreement Dated as of May __, 2018Warrant Agency Agreement • May 2nd, 2018 • Heat Biologics, Inc. • Pharmaceutical preparations • New York
WARRANT AGENCY AGREEMENT, dated as of May __, 2018 (“Agreement”), between Heat Biologics, Inc., a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New corporation (the “Warrant Agent”).
